US › Healthcare

Phaos Technology Holdings (Cayman) Limited (POAS)

US · Healthcare · Medical Devices

$2.65+22.69%

Last close · 2026-10-16

Latest quarter · ended 2026-07-31

Revenue

$36,303

Net profit

$-3.7M

EPS

$-0.12

EPS estimate

$0.00

Net margin

-10,114.8%

Key statistics

Market cap

$4.4M

Forward P/E

0.0

P/B

0.66

Book value

$0.13

EPS (TTM)

$-5.72

52-week high

$110.92

52-week low

$1.88

50-day MA

$0.17

200-day MA

$1.50

Shareholding

Insiders

29.98%

Institutions

4.46%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Phaos Technology Holdings (Cayman) Limited — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.